Atıcı, Y. Et Al. 2025. The effect of dubermatinib (TP-0903) combined with gemcitabine on apoptosis and anti-cancer activity in BxPC-3 cell line. 49th FEBS Congress , (İstanbul, Turkey), 290.

Atıcı, Y., Kara, H., & Sönmez, Ö., (2025). The effect of dubermatinib (TP-0903) combined with gemcitabine on apoptosis and anti-cancer activity in BxPC-3 cell line . 49th FEBS Congress (pp.290). İstanbul, Turkey

Atıcı, YASEMİN, Hatibe Kara, And Öner Sönmez. "The effect of dubermatinib (TP-0903) combined with gemcitabine on apoptosis and anti-cancer activity in BxPC-3 cell line," 49th FEBS Congress, İstanbul, Turkey, 2025

Atıcı, YASEMİN Et Al. "The effect of dubermatinib (TP-0903) combined with gemcitabine on apoptosis and anti-cancer activity in BxPC-3 cell line." 49th FEBS Congress , İstanbul, Turkey, pp.290, 2025

Atıcı, Y. Kara, H. And Sönmez, Ö. (2025) . "The effect of dubermatinib (TP-0903) combined with gemcitabine on apoptosis and anti-cancer activity in BxPC-3 cell line." 49th FEBS Congress , İstanbul, Turkey, p.290.

@conferencepaper{conferencepaper, author={YASEMİN ATICI Et Al. }, title={The effect of dubermatinib (TP-0903) combined with gemcitabine on apoptosis and anti-cancer activity in BxPC-3 cell line}, congress name={49th FEBS Congress}, city={İstanbul}, country={Turkey}, year={2025}, pages={290} }